Aim: To examine the differentiation induction and growth inhibition of HL-60 cells by diallyl disulfide (DADS), and its relationship with the alterations of histone acetylation and p21 WAF1 expression in vitro and in vivo. Methods: Differentiation was studied by nitroblue tetrazolium (NBT) reduction of HL-60 cell in vitro. HL-60 cells 5×10
Introduction
The development of agents that induce differentiation and/or apoptosis is a promising avenue for the treatment of human acute myeloid leukemia HL-60 cells. Epidemiologic studies offer evidence that a high garlic consumption reduces the risk of colorectal and stomach cancers [1] . These observations are supported by in vivo experiments carried out in rodents, concluding that garlic extract or garlic powder intake reduces chemically-induced carcinogenesis in different organs (the skin and the mammary gland) [2] [3] [4] . Diallyl disulfide (DADS) is a naturally occurring organosulfur compound derived from crushed garlic, which is the predominant lipid-soluble sulfide in essential garlic oil [5] . Some studies have shown that the antiproliferative activity of DADS is believed to be due to its ability to induce differentiation and/ or apoptosis and to arrest cells in the G 0 /G 1 or G 2 /M phase [6] [7] [8] [9] in A549 human lung cancer, T24 human bladder cancer, breast, colon cancer cells, etc [10] [11] [12] [13] . DADS-induced apopto-sis in human leukemia HL-60 cells is triggered by the generation of hydrogen peroxide, activation of caspase-3, degradation of poly(ADP-ribose) polymerase (PARP), and fragmentation of DNA [14] . In addition to the antiproliferative activity in cell culture and tumor xenograft models, DADS is highly effective for the prevention of chemically-induced cancers in animal models. Wattenberg et al were the first to demonstrate that N-nitrosodiethylamine-induced neoplasia of the forestomach in female A/J mice was inhibited by 90% upon po DADS administration prior to the carcinogen challenge [15] . The intragastric intubation of DADS also prevented colon and renal neoplasia in the multi-organ carcinogenesis model in male F344 rats [16] . The acetylation of histones appears to be an important mechanism for the regulation of gene transcription [17] [18] [19] . The acetylation of specific lysine residues, which occurs within the N-terminal domain of core histones, is one of the mechanisms involved in the modification of the chromatin structure, and is generally correlated with transcriptional gene activity. Histone acetylase (HAT) and deacetylase (HDAC) are emerging as important components of protein complexes that affect the dynamics of chromatin folding during gene transcription. In normal cells, histone acetylation levels are thought to result from an equilibrium between competing HAT and HDAC [20, 21] . Histone acetylation is often associated with activated transcription, and deacetylation correlates with transcriptional silencing. Recently, some studies have shown that DADS antiproliferation is related to the increase of histone acetylation. DADS antiproliferative effects in human colon tumor cell lines HT-29 and Caco-2 [22, 23] , and in DS19 mouse erythroleukemic cells [24] ,were associated with a transient increase of histone acetylation; moreover, DADS could inhibit nuclear HDAC activity. We previously reported that DADS could significantly inhibit the growth of MGC803 cells in vitro and in vivo, by activating p38 MAPK pathways to induce G2/M arrest of cells [25, 26] . DADS had a significant antiproliferative effect and could also induce differentiation in leukemia HL-60 cells [27] [28] [29] . The objective of the present work was to establish whether DADS suppresses proliferation and induces differentiation of HL-60 cells through increasing histone acetylation and the expression of p21 WAF1 in vitro and in vivo.
Materials and methods
Reagents DADS (purity 80%, the remaining 20% being diallyl trisulfide and diallyl sulfide), purchased from Fluka Co (Milwaukee, Wisconsin, USA), was dissolved in Tween 80 [28] at 8 g/L and stored at -20 °C. Sodium butyrate (SB), which was purchased from Sigma Co (St Louis, Montana, USA), was dissolved in PBS at 100 mmol/L and stored at -20 °C it was used as the positive control.
Animals The severe combined immunodeficiency (SCID) mice, eighteen 3-4-week-old male (11-12 g ), purchased from the Experimental Center of the Chinese Academy of Science in Shanghai, were fed common mouse feeds with eggs and maintained under specific pathogen-free conditions in the animal laboratory of our Cancer Research Institute.
Cell culture HL-60 cells, obtained from the Cancer Research Institute, Xiangya Medical College, Center South University in China, were cultured in RPMI-1640 medium with 10% fetal calf serum at 37 °C in a 5% CO 2 incubator.
Differentiation assays Nitroblue tetrazolium (NBT) reduction was performed by the previously described methods to measure the differentiation induction of the HL-60 cells [29] . Protein extraction Cultures of HL-60 cells in the logarithmic growth phase at a density of 2×10 5 cells per mL were cultured with 1.25 µg/mL DADS for 12, 24, 48, or 72 h at 37 °C. Cells cultured without DADS were harvested for comparison of histone acetylation levels. At the appropriate time point, the cells were harvested, washed with ice-cold PBS and suspended in 0.5 mL lysis buffer [10 mmol/L Tris-HCl (pH 7.6), 100 mmol/L NaCl, 1 mmol/L EDTA (pH 8.0) and 100 µg/mL PMSF] containing protease inhibitor aprotinin (1 µg/ mL). Lysates were centrifuged at 10 000×g for 10 min, and extracts were quantified using a background-corrected absorbance (BCA) protein quantified kit (Pierce, Rockford, IL, USA).
Inoculation of SCID mice HL-60 5×10 6 cells in the logarithmic growth phase were injected into the right side of the peritoneal cavity per mouse, and the mice were monitored until the peritoneal neoplasms were detected (28 d after the inoculation of the HL-60 cells).
Treatment of SCID mice with DADS SCID mice bearing HL-60 peritoneal neoplasms were randomly divided into 3 groups (6 mice per group). The mice received an ip injection of vehicle alone (NS), 42 mg/kg DADS or 73 mg/kg SB 3 times per week, for a total treatment period of 21 d. Injection volumes were kept constant at 0.2 mL for each mouse. Tumor length and width and abdomen circumference were measured twice weekly by vernier calipers, and tumor volume was calculated using the following formula:
Tumor volume=length×(width) 2 ×π/6 After 21 d of treatment, at which time the control animals (third and fifth) had large neoplasms which required the animals to be sacrified, all of the mice were killed 12 h after the final injection and the neoplasms and livers were removed. Tissues were flash-frozen in liquid nitrogen or fixed in formalin and embedded in paraffin. During the treatment period, the mice were weighed twice weekly and monitored for any overt signs of toxicity.
Cycle distribution analysis of HL-60 cells in SCID The cycle distribution of HL-60 cells in SCID was monitored by flow cytometry analysis as follows: 100 mg tumor tissues were cut into mono-cell suspension in ice-cold PBS. The suspension cells were enumerated by a counter, and 1×10 6 cells were pelleted by centrifugation. The supernatant was aspirated and the cells were resuspended in 1 mL of ice-cold ethanol (75%) and stored for 24 h at 4 °C. After the ethanol was removed, the cells were incubated with PBS containing RNase at 37 °C for 30 min and then stained for 30 min with propidium iodide. Sample data were collected using a Becton Dickinson FACS (Franklin Lakes, NJ, USA) and analyzed with Verity Winlist Software (Verity Software House, Topsham, ME, USA).
Tissue protein extraction Frozen tumor tissues 100 mg were ground under liquid nitrogen and washed in ice-cold PBS, the PBS was discarded and the tissues were suspended in 0.5 mL lysis buffer [10 mmol/L Tris-HCl (pH 7.6), 100 mmol/L NaCl, 1 mmol/L EDTA (pH 8.0) and 100 µg/mL PMSF] containing protease inhibitor aprotinin (1µg/mL). After centrifugation at 10 000×g for 10 min, the supernatant collected was analyzed for protein content using a BCA protein quantified kit (Pierce, Rockford, IL, USA).
Western blot analysis Total proteins (20-25 µg/point) were separated by 12% SDS-PAGE and transferred to a polyvinylidene fluoride membrane. The blots were blocked in 5% nonfat milk in Tris buffered saline (TBS) containing 0.1% Tween 20 for 2 h at room temperature, and incubated for 2 h at room temperature with the 1:1000 dilution of the acetylated histones H3 and H4 rabbit polyclonal primary antibodies (Upstate Biotechnology, Lake Placid, NY, USA) and with the 1:400 anti-p21 WAF1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The blots were washed for 3×5 min in TBS-T and then incubated with a 1: 1000 dilution of peroxidase-conjugated secondary antibody for 1 h at room temperature. The blots were again washed for 3×10 min in TBS-T and then developed by an enhanced chemiluminescence plus (ECL Plus) kit (Amersham Biosciences, Buckinghamshire, England). Where indicated, the blots were stripped and reprobed with antibodies directed against β-actin (Sigma-Aldrich, St Louis, Montana, USA).
Statistical analysis Data were expressed as Mean±SD. Group t-test was used to compare data between every 2 groups. One-way analysis of variance (ANOVA) was used to determine statistically significant differences among multiple groups. P<0.05 was considered statistically significant. Table  1 
Results

Differentiation induction by DADS in HL-60 cells
DADS increases p21
WAF1 protein expression in HL-60 cells The p21 WAF1 protein is an essential regulatory protein of cell cycle progression. Expression of its gene is partly regulated by histone acetylation. Since we observed that 1.25 µg/mL DADS induced histone hyperacetylation and increased HL-60 cell differentiation, we studied its effects on p21 WAF1 protein levels. DADS 1.25 µg/mL induced significant increases in p21 WAF1 protein levels after 24-h incubation (Figure 2 ).
Growth inhibition of the peritoneal neoplasm by DADS
In order to evaluate the effects of DADS on HL-60 cell growth in vivo, we examined its antitumor efficacy using a SCID mouse model. After 21 d of treatment, the animals were killed and the tumor sizes were determined. The mean tumor volume in mice treated with NS was 5.47±0.57 cm 3 , the mean tumor volume in mice treated with DADS was 1.85±0.30 cm 3 , and that in the group treated with SB was 1.92±0.30 cm 3 . The difference in tumor size between the mice treated with DADS and those treated with SB did not achieve statistical significance (P>0.05), whereas the group treated with DADS showed markedly suppressed tumor growth compared with the NS control (P<0.01) (Figure 3) .
To monitor any possible toxicity arising from the treatment, the mice from all of the treatment groups were weighed twice weekly during the 21-d treatment period, No difference was detected among bundles and no mouse died throughout the treatment period.
Cycle distribution of HL-60 cells in SCID The cycle distribution of HL-60 cells in SCID mice was monitored by flow cytometry analysis. The percentages of G 0 /G 1 or S phase cells in the NS group were 25.4% and 61.7%, respectively. In contrast, the 42 mg/kg DADS and 73 mg/kg SB treatment led to a significant inhibition of DNA synthesis as evidenced by the fact that the percentages of G 0 /G 1 phase cells increased to 63.4%; the S phase cells decreased to 27.8% in the DADS group (Figure 4) . protein, compared with tumors from the NS group; there was also a resemblance to the expression in the SB-treated group, an inhibitor of histone deacetylase ( Figure 6 ).
DADS increases acetylated histones in vivo
Discussion
This study demonstrates that DADS is a potent inhibitor of HL-60 cell growth in vitro and in vivo. In vitro, our previous work showed that 1.25 µg/mL DADS inhibited HL-60 cell proliferation and induced differentiation. The cell surface differentiation antigen CD11b increased from 12% (untreated) to 44% (treated by 1.25 µg/mL DADS for 3 d) (P <0.01). G0/G1 cells were added to 44.6% (P<0.01), but S and G 2 /M phase cells descended to 48.5% and 6.9% (P<0.01), respectively (the ratio of G 0 /G 1 , S, and G 2 /M phase in untreated HL-60 cells were 23%, 66% and 11%, respectively), and the cell cycle was arrested at the G 1 phase. Kinase activity of Janus kinase (JAK)/ signal transduction and activators of transcription (STAT) was tested by Western blot. The results demonstrated that the activity of phosphorylated Jak1 and Stat3 kinase was inhibited, the expression of Stat3 and c-myc gene decreased, c-fos and c-jun gene expression increased in HL-60 cells treated by DADS. The above results suggest that DADS could induce HL-60 cells differentiation toward granulocytic lineage, the inhibition of phosphorylated Jak1 and Stat3 was involved in HL-60 cell differentiation induced by DADS, and its possible molecular mechanism might relate to the modulation of proliferationassociated gene expression and inhibition of DNA synthesis [28] [29] [30] . In the present study, the NBT-reduction assay showed that the percentage of NBT-positive cells markedly increased after treatment with DADS, which suggests that DADS can induce differentiation of HL-60 cells. In vivo, the administration of DADS to SCID mice bearing HL-60 cells caused significant growth suppression of tumors at dose (42 mg/kg) with little detectable toxicity. Some studies have indicated that DADS inhibits the proliferation of human colon tumor cells [22, 23] , DS19 mouse erythroleukemia cells and K562 human leukemia cells [24] by increasing acetylated his- tured with the agent within 24 h. The increase of acetylated histone was observed in the HL-60 cell xenografts after the administration of 42 mg/kg DADS by ip injection 3 times a week in SCID mice. The effects were similar to that of SB, which is a potent histone deacetylase inhibitors (HDI) [31] . Consequently, we presume that DADS may serve as a potential HDI and inhibits HL-60 cell growth. HDI have been reported to induce G 1 or G 2 phase arrest and regulate the transcription of a number of cell cycle regulator genes, including p21, c-myc, cyclin and cdk [32] [33] [34] . HDI are currently receiving considerable attention as antitumor agents because of their ability to induce cell cycle arrest and/or cell death in a wide range of transformed cells in vitro and in vivo [35, 36] . Our previous work shows that DADS induced cell cycle arrest at the G 0 /G 1 phase on HL-60 cells in vitro [29] . Here we found that DADS also induced cell cycle arrest at the G 0 /G 1 phase on HL-60 cells in SCID mice in vivo. The cycle-dependent kinase inhibitor p21 WAF1 has been identified as a target induced by HDI in transformed cells [37] . The expression of p21 WAF1 in transformed cells after treatment with HDI was preceded by localized hyperacetylation of histones in the chromatin region containing the p21 WAF1 gene [38, 39] . These findings suggest that these agents act directly to induce hyperacetylation and thereby alter the chromatin structure in the region of the p21 WAF1 gene. Our results show that DADS could induce hyperacetylation of histones and increase the expression of p21 WAF1 in HL-60 cells. We then presume that DADS has an antitumor effect on HL-60 cells in vitro and in vivo because it could possibly cause hyperacetylation of histones in the promoter region of the p21 WAF1 gene. However, this requires further confirmation by chromatin immunoprecipitation assay.
In conclusion, DADS significantly inhibits the growth of human acute myeloid leukemia HL-60 cells in vitro and in vivo. The anticancer mechanism may involve the increase of histone acetylation, upregulation of p21 WAF1 and G 0 /G 1 phase arrest. DADS may be a potent antitumor agent for the management of human acute myeloid leukemia. tone in vitro. In the present study, we found that DADS caused the increase of acetylated histone in HL-60 cells cul-
